Viewing Study NCT07298005


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-01-10 @ 1:10 AM
Study NCT ID: NCT07298005
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sonlicromanol in Post-COVID: A Randomized, Double-blind, Placebo-controlled, Phase II Trial
Sponsor: Michele van Vugt
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module